Navigation Links
Report Highlights Key Activities that Drive Successful New Product Planning Groups in Pharmaceutical Industry
Date:8/24/2012

CHAPEL HILL, N.C., Aug. 24, 2012 /PRNewswire/ -- New Product Planning is called many things - New Product Commercialization, New Product Development, or just Commercial Planning. While the new product planning function goes by many names, those working in the role are all seeking the same result: successful product commercialization.

Some 3,000 medicines are in development in the United States for roughly 4,000 different indications. Still, the industry is grappling with depleted pipelines, fewer approvals and rising development costs. Understandably, the New Product Planning (NPP) function is under increasing pressure to perform and thus the function has found itself becoming involved earlier and earlier in the development cycle.

A new data-rich benchmarking study from research and consulting firm Best Practices, LLC delivers actionable insights on the critical elements of the new product planning (NPP) function. The study, Driving Growth through Planning, Structure and Activities: Best Practices in Pharmaceutical New Product Planning, identifies the full set of activities that NPP groups perform across the development cycle. Beyond examining the timing and reasons behind critical New Product Planning activities, this 72-page written report delves into how the function's structure and interactions with other functions play a role in its influence.

Best Practices, LLC used both field surveys and interviews to complete this study. In all, 27 New Product Planning leaders at 25 pharma companies across the globe contributed data. In-depth interviews were conducted with leaders from 13 of the participating companies. The research report reflects the current state of New Product Planning efforts at leading organizations.

Topics covered in this study include:

- NPP Group Structures, Roles and Responsibilities
- Interactions and Optimal Working Relationships between Regional and Global NPP Groups
- Examining the Full Set of Activities NPP Groups Perform, their timing, intended outcomes and value

To download a complimentary study excerpt, go to: http://www3.best-in-class.com/rr1173.htm.

ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.

 


'/>"/>
SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Report: Independent Drugstores, Policymakers Face New Challenges
2. Companion Diagnostics and Personalized Medicine Market Report 2012: Twease.org
3. SynCardia Total Artificial Heart Patient Featured in U.S. News & World Reports "Best Hospitals" Issue
4. China Nepstar Chain Drugstore Reports Second Quarter 2012 Financial Results
5. MGC Diagnostics Corporation to Report Third Quarter Fiscal 2012 Financial Results on Thursday, August 30, 2012
6. China Kanghui Holdings Reports Second Quarter 2012 Financial Results
7. Concord Medical Reports Second Quarter 2012 Financial Results
8. Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies
9. Organovo Reports Q2 2012 Financial Results, Provides Business Update
10. ULURU Inc. Reports Second Quarter 2012 Financial Results
11. China Pharma Holdings, Inc. Reports Second Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... 24, 2017 IBM (NYSE: IBM ) has ... for Solid-State Arrays (SSA) for the fourth year in a ... to Gartner, "Vendors in the Leaders quadrant have the highest ... A vendor in the Leaders quadrant has the market share, ... acceptance of new technologies. These vendors demonstrate a clear understanding ...
(Date:7/21/2017)... Did you know that PhRMA member companies invested $65.5 ... spending on brand medicines, generics and the supply chain account for ... just half of this (7 percent)? Or that the ... venture capital investments in high-growth biopharmaceutical startups? ... The biopharmaceutical ...
(Date:7/14/2017)... 14, 2017 Endo International plc (NASDAQ: ENDP ... 8, 2017.  Members of its senior management team will host a ... 8:30 a.m. ET. The dial-in number to access ... (678) 509-7598, and the passcode is 45397076. Please dial in 10 ... A replay of the call will be available ...
Breaking Medicine Technology:
(Date:7/25/2017)... ... July 25, 2017 , ... ... provider in the United States, today announced its partnership with financial technology company, ... , The foundation of the solution lies within Hyosung’s superior ATMs, assisted self-service ...
(Date:7/24/2017)... , ... July 24, 2017 , ... Engineers at the ... because it produces the same kind of electrical energy that the body uses. ... of moving electrons. This flow of electrons out of the battery is generated by ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... federal Substance Abuse and Mental Health Services Administration’s (SAMHSA) State Targeted Response to ... Department of Health Care Services, will facilitate the development of a hub and ...
(Date:7/24/2017)... ... 2017 , ... Every year, thousands of dedicated Higher Education and K12 professionals ... is coupled with a dynamic theme like Camp Canvas; this year, they’ve managed to ... , To extend their partnership with Canvas beyond the LMS integration, Modo Labs ...
(Date:7/24/2017)... Solana Beach, California (PRWEB) , ... July 24, ... ... and commercialization of autologous fat (adipose) transfer systems announces the issuance of United ... (the ‘324 patent) for its adipose filtration technology. The '398 and '324 ...
Breaking Medicine News(10 mins):